STOCK TITAN

[ARS] Lineage Cell Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Lineage Cell Therapeutics, Inc.

ARS Filing - Lineage Cell Therapeutics, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Lineage Cell Therapeutics, Inc. (LCTX)

Acceptance Date: 2026-04-29T16:20:06.000Z

View PDF Document